Summary by Moomoo AI
On February 23, 2024, Panacea Venture Healthcare Fund II, L.P., led by Founding Managing Partner James Huang, reported the purchase of 3.1 million American Depositary Shares (ADSs) of Connect Biopharma Holdings Limited through a series of open market transactions. These shares were acquired at a weighted average price of $0.9836 per ADS. The transactions were funded by capital contributions from the partners of Panacea Venture Healthcare Fund II, L.P. As a result of these purchases, Panacea Venture Healthcare Fund II, L.P., along with Panacea Innovation Limited, Panacea Venture Healthcare Fund II GP Company, Ltd., and James Huang, collectively hold 12,000,000 Ordinary Shares of Connect Biopharma, representing 21.8% of the company's class of shares. This stake makes them one of the largest shareholders...Show More